Bayesian Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-53,909
Closed -$640K 602
2024
Q4
$640K Buy
+53,909
New +$919K 0.08% 320
2024
Q3
Sell
-20,274
Closed -$484K 671
2024
Q2
$484K Buy
+20,274
New +$476K 0.06% 379
2023
Q4
Sell
-14,600
Closed -$126K 744
2023
Q3
$126K Sell
14,600
-3,000
-17% -$21.3K 0.01% 590
2023
Q2
$139K Sell
17,600
-16,100
-48% -$112K 0.01% 673
2023
Q1
$251K Buy
+33,700
New +$335K 0.03% 556

Other funds holding ASPN

Bayesian Capital Management's ASPN Position: Q1 2025 in Review

Bayesian Capital Management sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 53,909 shares — an estimated $640K sold.

Bayesian Capital Management first reported a position in ASPN in Q1 2023 and held it in 5 quarters. The position peaked at $640K in Q4 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Bayesian Capital Management reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 53,909 Aspen Aerogels shares in Q1 2025, an estimated $640K.
  • Bayesian Capital Management first reported a position in Aspen Aerogels in Q1 2023 and held it in 5 quarters.
  • Bayesian Capital Management's Aspen Aerogels position peaked at $640K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.